AAPL 192.4902 0.7591% MSFT 429.38 0.9498% GOOG 179.04 0.325% GOOGL 177.45 0.2996% AMZN 182.02 -0.8282% NVDA 947.4001 -0.0422% META 464.53 -0.9193% TSLA 186.0554 6.3478% TSM 153.42 -0.0847% LLY 803.85 2.6392% V 276.17 -0.8509% AVGO 1399.41 -1.0339% JPM 198.68 1.585% UNH 522.2967 0.9796% NVO 134.5401 1.2265% WMT 64.9 1.1218% LVMUY 166.815 -1.2052% XOM 118.03 -0.5393% LVMHF 846.034 0.1224% MA 457.885 -0.3862%

Össur hf

Healthcare US OSSUY


Last update at 2024-05-20T13:30:00Z

Day Range


52 Week Range



Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 56.17M 86.64M 12.72M 90.27M 96.92M
Minority interest -0.69700M -1.66200M 4.68M 4.59M -0.06900M
Net income 42.51M 63.99M 6.21M 66.04M 79.75M
Selling general administrative 338.58M 328.03M 306.95M 301.50M 272.43M
Selling and marketing expenses - - - - -
Gross profit 439.75M 455.39M 391.24M 438.65M 386.80M
Reconciled depreciation 49.37M 51.64M 64.70M 43.56M 28.39M
Ebit 67.14M 95.62M 53.27M 99.23M 90.52M
Ebitda 116.74M 148.08M 87.03M 142.16M 129.07M
Depreciation and amortization - - - - -
Non operating income net other - - - - 0.00000M
Operating income 67.14M 95.62M 53.27M 105.83M 83.02M
Other operating expenses - - - - 0.00000M
Interest expense 11.20M 9.80M 9.61M 8.33M 3.76M
Tax provision 12.96M 20.98M 4.80M 21.39M 17.10M
Interest income 0.78M 0.17M 0.46M 1.02M 0.36M
Net interest income -11.64100M -12.18600M -9.97800M -8.98200M -4.35400M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense 12.96M 20.98M 4.80M 21.39M 17.10M
Total revenue 718.65M 718.67M 629.50M 686.26M 612.88M
Total operating expenses 651.51M 623.04M 576.24M 580.44M 529.86M
Cost of revenue 278.90M 263.28M 238.27M 247.61M 226.07M
Total other income expense net - - - -15.55900M 6.41M
Discontinued operations - - - - 0.00000M
Net income from continuing ops 43.21M 65.66M 7.92M 68.87M 79.82M
Net income applicable to common shares 42.51M 63.99M 6.21M 66.04M 79.75M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 1325.36M 1246.91M 1214.33M 1090.67M 913.55M
Intangible assets 62.00M 58.84M 59.50M 62.66M 49.11M
Earning assets - - - - -
Other current assets 8.86M 8.35M 6.02M 5.74M 4.04M
Total liab 689.85M 620.32M 637.14M 521.72M 376.02M
Total stockholder equity 635.70M 621.59M 572.51M 564.37M 534.46M
Deferred long term liab - - - - 0.00000M
Other current liab 58.17M 30.99M 31.20M 32.22M 17.20M
Common stock 4.78M 4.79M 4.79M 4.79M 4.81M
Capital stock 4.78M 4.79M 4.79M 4.79M 93.77M
Retained earnings 641.23M 593.20M 530.42M 534.93M 488.36M
Other liab 58.76M 53.00M 41.84M 43.70M 36.41M
Good will 680.40M 644.15M 612.19M 521.05M 500.84M
Other assets 41.04M 29.97M 31.45M 30.08M 20.57M
Cash 76.63M 85.20M 102.36M 58.61M 55.71M
Cash and equivalents - - - - -
Total current liabilities 237.01M 186.46M 147.31M 141.08M 117.56M
Current deferred revenue - - - - -
Net debt 263.15M 223.04M 255.16M 192.51M 179.78M
Short term debt - - - 7.19M 0.00000M
Short long term debt 62.07M 46.04M 17.55M 7.19M 13.43M
Short long term debt total - - - - -
Other stockholder equity -71.73500M -47.18400M -32.78100M -48.37500M -47.66300M
Property plant equipment 179.32M 182.08M 171.38M 163.41M 63.03M
Total current assets 348.85M 318.23M 326.46M 307.38M 274.01M
Long term investments - - - 7.91M 7.68M
Net tangible assets -106.69900M -81.40300M -99.18100M -19.33800M -15.49100M
Short term investments - - - - 0.00000M
Net receivables 116.74M 102.77M 112.00M 116.26M 107.75M
Long term debt 277.71M 262.19M 339.98M 243.93M 222.05M
Inventory 132.13M 103.98M 93.23M 112.01M 95.86M
Accounts payable 28.65M 26.72M 20.02M 26.68M 28.14M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income - - - - 0.00000M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other 0.00100M - - -0.00100M -0.00100M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 976.51M 928.68M 887.87M 783.29M 639.55M
Capital lease obligations 141.15M 139.92M 125.87M 109.10M 0.00000M
Long term debt total - - - - 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -66.26100M -59.44700M -106.44900M -62.36400M -92.14300M
Change to liabilities 10.94M 7.76M -7.90500M 0.90M -1.64300M
Total cashflows from investing activities -66.26100M -59.44700M -106.44900M -62.36400M -92.14300M
Net borrowings 14.36M -49.74300M 67.67M 1.94M 73.23M
Total cash from financing activities 3.79M -51.07300M 51.86M -29.29800M 44.37M
Change to operating activities 11.58M 11.58M 11.58M 11.58M 1.97M
Net income 42.51M 63.99M 6.21M 66.04M 79.75M
Change in cash -8.56600M -17.16600M 43.75M 2.90M 18.43M
Begin period cash flow 85.20M 102.36M 58.61M 55.71M 37.27M
End period cash flow 76.63M 85.20M 102.36M 58.61M 55.71M
Total cash from operating activities 60.77M 100.53M 92.24M 95.28M 69.44M
Issuance of capital stock - - - - -
Depreciation 43.49M 45.54M 42.20M 38.27M 19.06M
Other cashflows from investing activities 1.47M 1.18M -6.14100M -0.06700M 4.43M
Dividends paid - - 9.28M 9.06M 9.18M
Change to inventory -28.62000M -15.78300M 12.75M -14.66700M -13.91000M
Change to account receivables -13.45700M -13.18400M 18.45M -11.22600M -1.77600M
Sale purchase of stock -9.94100M - - - -19.25600M
Other cashflows from financing activities -0.63000M -1.33000M -2.59400M -1.57600M -0.42200M
Change to netincome -11.55500M -11.55500M 14.61M 10.68M -19.09600M
Capital expenditures 16.55M 16.96M 13.77M 19.89M 21.89M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital -19.55200M -21.20900M 23.29M -21.60900M -15.36400M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow 34.83M 73.84M 68.22M 63.43M 38.58M


  • Previous Close 9.00
  • Market Cap1702.21M
  • Volume0
  • P/E Ratio31.15
  • Dividend Yield1.84%
  • EBITDA99.60M
  • Revenue TTM766.43M
  • Revenue Per Share TTM1.80
  • Gross Profit TTM 439.75M
  • Diluted EPS TTM0.13

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
Össur hf
- -% 9.00 31.15 - 2.22 2.52 2.73 15.50
Abbott Laboratories
-0.4689 0.45% 102.74 37.15 23.15 4.67 4.97 4.88 19.38
Stryker Corporation
-0.23 0.07% 329.50 44.07 24.94 5.51 6.12 6.05 25.73
Medtronic PLC
0.57 0.68% 85.08 26.60 15.87 3.35 2.08 3.90 14.12
Boston Scientific Corp
0.36 0.48% 75.72 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News


Össur hf., together with its subsidiaries, engages in the design, development, production, and sale of non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company operates through two segments: Prosthetics and Bracing & Supports. The Prosthetics segment offers mechanical products, such as lower limb prosthetics and finger prostheses; and bionic products microprocessor-controlled feet, knees, hands, liners, fingers, and other components integrated with sensors, computing power, internal intelligence, and actuators for amputees. The Bracing & Supports segment provides bracing and supports products, such as supporting devices for spinal, knee, hip, foot, ankle, and hands that are primarily used to support joints and other body parts for therapeutic and preventative purposes; and injury solutions to enhance the healing process of fractures and ligament injuries. It serves specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgery centers. The company sells its products through its direct sales networks and distributors. Össur hf. was incorporated in 1971 and is headquartered in Reykjavik, Iceland. Össur hf. is a subsidiary of William Demant Invest A/S.

Össur hf

Grjothals 1-5, Reykjavik, Iceland

Key Executives

Name Title Year Born
Mr. Sveinn Solvason Pres & CEO 1978
Mr. Ossur Kristinsson Founder 1943
Ms. Gudny Arna Sveinsdottir Chief Financial Officer 1966
Mr. Egill Jonsson Exec. VP of Manufacturing & Operations 1957
Edda Lara Luovigsdottir Investor Relations Director NA
Ms. Sigurborg Arnarsdottir Compliance Officer NA
Ms. Margret Lara Fridriksdottir Exec. VP of HR & Corp. Strategy 1978
Mr. Olafur Gylfason Exec. VP of Prosthetics & Europe/Emerging Markets 1969
Mr. Gudjon G. Karason Exec. VP of Clinics 1969
Mr. Christian Robinson Exec. VP of Bracing & Supports and Americas 1982

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).